SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-21-013294
Filing Date
2021-05-25
Accepted
2021-05-25 16:46:20
Documents
1
Period of Report
2021-05-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3678
  Complete submission text file 0001437749-21-013294.txt   5024
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Issuer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address WANGQUIAO NO. 1000, PUDONG NEW AREA SHANGHAI F4 F4
Business Address
Li Xinzhou (Reporting) CIK: 0001565534 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33678 | Film No.: 21961281